Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.
Non-motor symptoms are a key component of Parkinson's disease, possibly representing a clinical biomarker of its premotor phase. The burden of non-motor symptoms can define a patient's health-related quality of life. Non-motor symptoms substantially increase the cost of care-requiring increased hospitalisation and treatment-and pose a major challenge to healthcare professionals. However, clinicians often regard non-motor symptoms and their management as peripheral to that of the motor symptoms. Here, we address the clinical issues and unmet needs of non-motor symptoms in Parkinson's disease.
Department of Neurology, National Parkinson Foundation Centre of Excellence, King's College Hospital, and Kings College, London, UK.
Antoniya
A
Todorova
Institute of Pharmaceutical Science, King's College London, London, UK.
Peter
P
Jenner
Department of Neurology, National Parkinson Foundation Centre of Excellence, King's College Hospital, and Kings College, London, UK.
K
K
Ray Chaudhuri
D000978:Antiparkinson Agents / Q000009:adverse effects; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D011788:Quality of Life; D012720:Severity of Illness Index
D000978:Antiparkinson Agents
NMSQuest; NON MOTOR SYMPTOMS; PARKINSON'S DISEASE